ELMSFORD, N.Y.--(BUSINESS WIRE)--BioScrip, Inc. (Nasdaq: BIOS) today reported net income for the quarter ended September 30, 2008 of $1.4 million, or $0.04 per diluted share, on revenue of $359.4 million, compared to $1.7 million, or $0.04 per diluted share, on revenue of $297.6 million in the third quarter of 2007. BioScrip’s 2008 results include a one-time charge of $795,000, or $0.02 per share as a result of a civil settlement with the U.S. Office of The Inspector General (“OIG”) related to conduct beginning in 2003 and ending when the Company self-reported in late 2006.
